Loading organizations...
Loading organizations...
Biotechnology company developing small molecules for blood cancers.
Ajax Therapeutics has raised $135.0M across 2 funding rounds.
Ajax Therapeutics has raised $135.0M in total across 2 funding rounds.
Ajax Therapeutics has raised $135.0M in total across 2 funding rounds.
Ajax Therapeutics's investors include Ming Cheah, Boxer Capital, EcoR1 Capital, Eli Lilly and Company, Inning One Ventures, Point72, RA Capital Management, Schr"dinger, Vivo Capital, Scott Platshon, Martin Vogelbaum, Ross Levine.
Ajax Therapeutics has raised $135.0M across 2 funding rounds. Most recently, it raised $95.0M Series C in May 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 13, 2024 | $95.0M Series C | Ming Cheah | Boxer Capital, EcoR1 Capital, Eli Lilly and Company, Inning One Ventures, Point72, RA Capital Management, Schr"dinger, Vivo Capital |
| Jun 1, 2021 | $40.0M Other Equity | Scott Platshon | Boxer Capital, Martin Vogelbaum, Ross Levine, NYU Langone Health, Ramy Farid |